A study to learn about the effects and safety of tazemetostat in people with integrase interactor-1 (INI-1) negative tumours or replapsed or refractory synovial sarcoma - Global

A study to learn about the effects and safety of tazemetostat in people with integrase interactor-1 (INI-1) negative tumours or replapsed or refractory synovial sarcoma

Back

A study to learn about the effects and safety of tazemetostat in people with integrase interactor-1 (INI-1) negative tumours or replapsed or refractory synovial sarcoma

- 26 January 2025 - 1 mins read
A study to learn about the effects and safety of tazemetostat in people with integrase interactor-1 (INI-1) negative tumours or replapsed or refractory synovial sarcoma

Tazverik

Related Documents

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.